Naratriptan: a review (Q36181337)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Naratriptan: a review	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Naratriptan: a review (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

author name string

Mathew NT

1

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

687-695

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.687

21 January 2018

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.687

21 January 2018

The Mode of Action of Sumatriptan is Vascular? A Debate

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.687

21 January 2018

Naratriptan: biological profile in animal models relevant to migraine

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.687

21 January 2018

Human 5-HT1F receptor-stimulated [35S]GTPgammaS binding: correlation with inhibition of guinea pig dural plasma protein extravasation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.687

21 January 2018

Effect of subcutaneous naratriptan on forearm blood flow.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.687

21 January 2018

Coronary side-effect potential of current and prospective antimigraine drugs

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.687

21 January 2018

Lack of antinociceptive activity of sumatriptan in rodents

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.687

21 January 2018

Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.687

21 January 2018

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.687

21 January 2018

Identifiers

10.1517/13543784.8.5.687

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36181337&oldid=1988884473"